semaglutide dr berg as a GLP-1 Agonist: A Breakthrough in Obesity Treatment You're Being Lied To About

But there's not enough data to say for sure

Randomized controlled trials have shown that Semaglutide is effective in promoting weight loss compared to a placebo

Saxenda is specifically approved for weight management in individuals with obesity or those with a BMI of 27+ who have obesity-related conditions (e.g., high blood pressure, type 2 diabetes)

Key takeaways Ozempic is not currently used in dogs

[5] [6] The medication works by mimicking the action of endogenous GLP-1, enhancing glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety through central nervous system pathways